Hepatocyte Nuclear Factor 4α (HNF4α) Plays a Controlling Role in Expression of the Retinoic Acid Receptor β (RARβ) Gene in Hepatocytes
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24108608 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Reza Zolfaghari und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutritional Sciences, Pennsylvania State University, University Park, PA 16802, USA. Hauptthemen laut MEDLINE: Hepatocyte Nuclear Factor 4, Hepatocytes, Tretinoin, Receptors, Retinoic Acid. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, intramural research program of the National Cancer Institute of NIH (JAB and FJG), Dorothy Foehr Huck Endowment (ACR).
Abstract (Originalsprache)
HNF4α, a member of the nuclear receptor superfamily, regulates the genes involved in lipid and glucose metabolism. The expression of the RARβ gene in the liver of HNF4α knock-out mice was higher versus wildtype controls, whereas oppositely, RARβ promoter activity was 50% reduced by the overexpression of HNF4α in HepG2 cells, and treatment with retinoic acid (RA), a major metabolite of vitamin A, increased RARβ promoter activity 15-fold. The human RARβ2 promoter contains two DR5 and one DR8 binding motifs, as RA response elements (RARE) proximal to the transcription start site. While DR5 RARE1 was previously reported to be responsive to RARs but not to other nuclear receptors, we show here that mutation in DR5 RARE2 suppresses the promoter response to HNF4α and RARα/RXRα. Mutational analysis of ligand-binding pocket amino acids shown to be critical for fatty acid (FA) binding indicated that RA may interfere with interactions of FA carboxylic acid headgroups with side chains of S190 and R235, and the aliphatic group with I355. These results could explain the partial suppression of HNF4α transcriptional activation toward gene promoters that lack RARE, including APOC3 and CYP2C9, while conversely, HNF4α may bind to RARE sequences in the promoter of the genes such as CYP26A1 and RARβ, activating these genes in the presence of RA. Thus, RA could act as either an antagonist towards HNF4α in genes lacking RAREs, or as an agonist for RARE-containing genes. Overall, RA may interfere with the function of HNF4α and deregulate HNF4α targets genes, including the genes important for lipid and glucose metabolism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nutritional Sciences, Pennsylvania State University, University Park, PA 16802, USA.
- Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814, USA.
ORCID-Profile: A Catharine Ross
Förderung
- NCI NIH HHS
- intramural research program of the National Cancer Institute of NIH (JAB and FJG)
- Dorothy Foehr Huck Endowment (ACR)
Zitieren
APA
Zolfaghari, R., Bonzo, J. A., Gonzalez, F. J., & Ross, A. C. (2023). Hepatocyte Nuclear Factor 4α (HNF4α) Plays a Controlling Role in Expression of the Retinoic Acid Receptor β (RARβ) Gene in Hepatocytes. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24108608
Vancouver
Zolfaghari R, Bonzo JA, Gonzalez FJ, Ross AC. Hepatocyte Nuclear Factor 4α (HNF4α) Plays a Controlling Role in Expression of the Retinoic Acid Receptor β (RARβ) Gene in Hepatocytes. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24108608
BibTeX
@article{Zolfaghari2023,
author = {Zolfaghari, Reza and Bonzo, Jessica A and Gonzalez, Frank J and Ross, A Catharine},
title = {Hepatocyte Nuclear Factor 4α (HNF4α) Plays a Controlling Role in Expression of the Retinoic Acid Receptor β (RARβ) Gene in Hepatocytes},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24108608}
}
EUVIMED